JPH203 also inhibited proliferation of all three lymphoma cell lines but not that of HEK293 cells (Fig. 8C–F), suggesting that inhibition of LAT1 is a potent therapeutic modality for NHL. The gene discussed is SLC7A5; the disease is lymphoma.